Good MorningEquity markets were mixed and flat early on Thursday as market momentum waned. However, the day turned into a rout for the bulls following hawkish comments from Fed chief Jerome Powell. He says the Fed is not confident that it has done enough to tame inflation, and more rate hikes may be needed. This is contrary to a recently firmed opinion that the Fed was near the cycle's peak and put a cap on equities.
The S&P 500 is showing resistance near recent highs and may not be able to move much higher without another catalyst. The next big market-moving events will come next week with reports from major retailers and the CPI report. The CPI may show another cooling in inflation and provide a lift for equities; the risk is that a CPI-driven rally may quickly reverse when Target and Walmart report later in the week. Walmart has been a resilient player, gaining market share and controlling shrinkage, while Target loses share and struggles with theft. Featured: Sell these "safe" blue chips immediately (Ad) 
|
Healthcare | |
Eli Lilly & Co. (NYSE: LLY) reversed lower on November 9. This came after LLY stock advanced 3.20% after the company got regulators' OK for its weight-loss drug Zepbound.
In clinical trials, the drug helped people lose as much as 52 pounds within a 16-month timeframe.
Zepbound is based on ti... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Finance | |
It's not as exciting or cutting-edge as technology stocks, but the iShares U.S. Insurance ETF (NYSEARCA: IAK) has been edging higher in the past month.
Ignore this so-called "boring" industry at your own peril.
Drivers behind the move include higher interest rates and volume of net premiums.
I... Read the Full Story |
|
Consumer Discretionary | |
Etsy Inc. (NASDAQ: ETSY) has been crafting a downtrend but may be stitching up a bottom to its year-long slide.
On November 1, the online marketplace for handmade and vintage items posted earnings growth for the first time since December 2021. Revenue grew by 7% to $636.3 million.
A look at Mar... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Communication Services | |
Roblox (NASDAQ: RBLX) and Take-Two Interactive (NASDAQ: TTWO) produced solid Q3 reports, which is really no surprise. The gaming industry has a loyal following with the release of new titles and deepening penetration of markets to drive business. Also, it is unsurprising that gaming stocks have hi... Read the Full Story |
|
Consumer Staples | |
With emerging markets expected to outperform globally in 2024 and consumer products like Coca-Cola gaining traction, Coca-Cola bottlers such as Coca-Cola EuroPacific Partners (NYSE: CCEP) are an excellent group to invest in. Not only do they provide exposure to international and emerging markets, ... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Technology | |
Up to last week, shares of chipmaker Qualcomm Inc (NASDAQ: QCOM) had been trading largely sideways since this time last year, with several recent attempts from the bears to send them down to fresh lows. They've been fighting the current for some time, and with their shares having sank 50% from las... Read the Full Story |
|
Healthcare | |
The 2023 version of the U.S. stock market must have recently picked up Johnson & Johnson product Listerine — because it has good…wait for it…‘breadth.’
In investment terminology, market breadth refers to how many stocks are going up compared to how many are goi... Read the Full Story |
|
Consumer Discretionary | |
On the surface, Airbnb Inc. (NASDAQ: ABNB), Intel Corp. (NASDAQ: INTC) and Live Nation Entertainment Inc. (NYSE: LYV) don’t seem to have much in common. However, all three recently trounced profit views, despite facing vastly different industry situations.
When a company tops earnings views... Read the Full Story |
|
Industrials | |
It’s one thing to understand what the S&P 500 is doing, by tracking the SPDR S&P 500 ETF Trust (NYSEARCA: SPY). But drilling down a little more gives you a better indication of market breadth, or lack thereof, as well as what sectors might be poised for rallies or reversals.
For exa... Read the Full Story |
|
Consumer Staples | |
The Altria Group Inc. (NYSE: MO) has been reinventing itself, transitioning more towards smokeless tobacco products. Tobacco smoking has been trending lower for years. The percentage of adult smokers in the United States has declined from 42.6% in 1965 to 13.7% in 2018 and is expected to fall towa... Read the Full Story |
|
Friday's Early Bird Stock Of The Day STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. | | View Today's Stock Pick |
|
